Building Organoids to Combat Cancer
Shivem Shah is one of a new generation of scientists who are developing therapies that will modulate the immune system to combat disease. They are called immunoengineers. A fourth-year biomedical engineering PhD Student, Shah first became interested in biomedical engineering because of the opportunity to create therapies for diseases with inadequate treatments. He is specifically drawn to immunoengineering for its potential to treat and possibly even cure diseases with poor prognosis, such as cancer.
Ferra Pinnock, Ph.D. student in Cornell’s Robert Frederick Smith School of Chemical and Biomolecular Engineering (CBE), and Susan Daniel, Associate Professor at the Smith School, have been awarded a... Read more about Smith School graduate student and professor win coveted Gilliam Fellowship